FreeCME

Current Strategies in the Diagnosis and Treatment of Multiple Sclerosis

Available until October 30, 2014

Target Audience:

This webcast is directed primarily to neurologists, neuroradialogists, pharmacists, registered nurses, physician assistants, nurse practitioners and other health care professionals interested in new developments for treatment of multiple sclerosis. No specific skill or knowledge other than a basic training in neurology is required for successful participation in this activity.

Program Overview:

This webcast is intended to improve care of patients with multiple sclerosis by accelerating adoption of new guidelines and evidence-based practice change. This webcast will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and MedNet.

This activity is supported by educational grants from: Genzyme, a SANOFI company, Teva Pharmaceuticals and EMD-Serono.

Module 1 — Elliot M. Frohman — 1.25 AMA PRA Category 1™ Credit Hours

Module 2 — B. Mark Keegan & James M. Stankiewicz — 1.25 AMA PRA Category 1™ Credit Hours

Module 3 — Matilde Inglese & Harold Moses — 1.25 AMA PRA Category 1™ Credit Hours

Module 4 — Clyde E. Markowitz — 0.75 AMA PRA Category 1™ Credit Hours

Module 5 — Andrew Goodman — 0.75 AMA PRA Category 1™ Credit Hours

Module 6 — David Brandes & Theresa C. Frohman — 1.0 AMA PRA Category 1™ Credit Hours